Back to Newsroom
Novavax Reports Third Quarter 2016 Financial Results
GAITHERSBURG, Md., Nov. 09, 2016 (GLOBE NEWSWIRE) — Novavax, Inc., (Nasdaq:NVAX) today announced its financial results for the third quarter and nine months ended September 30, 2016, in conjunction with its Investor and Analyst Day update.
The Company presented a restructuring plan designed to meet the following key objectives:
- Prioritize development activities to achieve clinical data events within 2017;
- Reduce cash burn, extend financial horizon and minimize near-term dilution; and
- Maintain operational core competencies to execute development plans.
Click here to read the full release